Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An updated analysis Meeting Abstract


Authors: André, T.; Hong, D.; Deeken, J.; Italiano, A.; Liu, T.; Burcoveanu, D.; Norenberg, R.; Mussi, C.; Xu, R.; Drilon, A.; Shen, L.
Abstract Title: Long-term efficacy and safety of larotrectinib in patients with tropomyosin receptor kinase (TRK) fusion gastrointestinal (GI) cancer: An updated analysis
Meeting Title: 25th World Congress on Gastrointestinal Cancer (ESMO 2023)
Keywords: oncology
Journal Title: Annals of Oncology
Volume: 34
Issue: Suppl. 1
Meeting Dates: 2023 Jun 28-Jul 1
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2023-06-01
Start Page: S12
End Page: S13
Language: English
ACCESSION: WOS:001037960400501
DOI: 10.1016/j.annonc.2023.04.055
PROVIDER: wos
Notes: Meeting Abstract: PD-28 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    637 Drilon